Supplementary Figure 4 from Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes

David König; Michael T. Sandholzer; Sarp Uzun; Andreas Zingg; Reto Ritschard; Helen Thut; Katharina Glatz; Elisabeth A. Kappos; Dirk J. Schaefer; Christoph Kettelhack; Jakob Passweg; Andreas Holbro; Katharina Baur; Michael Medinger; Andreas Buser; Didier Lardinois; Lukas T. Jeker; Nina Khanna; Frank Stenner; Benjamin Kasenda; Krisztián Homicskó; Matthias S. Matter; Natália Rodrigues Mantuano; Alfred Zippelius; Heinz Läubli

doi:10.1158/2326-6066.26144567.v1

Abstract

Supplementary Figure 4. Progressing lung metastasis (Wedge resection 61 weeks after TIL transfer). The resected lung metastasis is Melan-A positive without any desmoplastic component.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

König et al. (2024) studied this question.

synapsesocial.com/papers/68e61b74b6db6435875ae030 https://doi.org/10.1158/2326-6066.26144567.v1

View Full Paper

Ask AI

Bookmark

Share

Supplementary Figure 4 from Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes

Abstract

Discussion

Cite This Study

Supplementary Figure 4 from Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes

Abstract

Discussion

Cite This Study

Keep reading

Keep reading